Biosafety Level 2 (BL2) Pilotplant facility for the production of viral particles and recombinant proteins using mammalian cells. Facilities for mammalian cell products : From design through validation

AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
ConferenceInternational annual meeting, The Williamsburg Bioprocessing Foundation, Montreal, Quebec, June 22-25, 1998
Subjectbio
LanguageEnglish
AffiliationNRC Biotechnology Research Institute; National Research Council Canada
Peer reviewedNo
NRC numberCPBIO18
NPARC number3539621
Export citationExport as RIS
Report a correctionReport a correction
Record identifier39945323-7a26-4df7-8a3c-b379c29b59d9
Record created2009-03-01
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)